tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Charles Pitman, 1 are a HOLD (50%), 1 are a BUY (50%).
Analyst Charles Pitman, currently employed at BARCLAYS, carries an average stock price target met ratio of 100% that have a potential upside of 19.82% achieved within 285 days.
Charles Pitman’s has documented 3 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ARGX, argenx NV ADR at 06-Aug-2024.
Analyst best performing recommendations are on ARGX (ARGENX NV ADR).
The best stock recommendation documented was for ARGX (ARGENX NV ADR) at 9/23/2021. The price target of $381.03 was fulfilled within 285 days with a profit of $63.02 (19.82%) receiving and performance score of 0.7.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 16-Nov-2017
$1000
$199.99 (25.00%)
$1000
8 days ago
(14-Jan-2026)
20/22 (90.91%)
$200.67 (25.10%)
119
Buy
Since 13-May-2025
$858
$57.99 (7.25%)
$680
1 months 4 days ago
(18-Dec-2025)
13/13 (100%)
$-4.05 (-0.47%)
141
Buy
Since 13-Sep-2018
$1264
$463.99 (58.00%)
$741
1 months 6 days ago
(16-Dec-2025)
19/20 (95%)
$412.58 (48.46%)
198
Buy
Since 29-May-2020
$1100
$299.99 (37.50%)
$925
1 months 14 days ago
(08-Dec-2025)
16/17 (94.12%)
$199.24 (22.12%)
198
Buy
Since 03-May-2022
$1110
$309.99 (38.75%)
$1040
1 months 18 days ago
(04-Dec-2025)
20/22 (90.91%)
$194.03 (21.18%)
190
What Year was the first public recommendation made by Charles Pitman?
